Kips Bay Medical Chairman and CEO Manny Villafaña to Present Keynote Address at the Aegis 2013 Health Care Conference

  Kips Bay Medical Chairman and CEO Manny Villafaña to Present Keynote Address
  at the Aegis 2013 Health Care Conference

Business Wire

MINNEAPOLIS -- September 12, 2013

Kips Bay Medical, Inc. (NASDAQ: KIPS), a medical device company focused on
manufacturing and commercializing its external saphenous vein support
technology, eSVS® Mesh, for use in coronary artery bypass grafting surgery
(CABG), announced that Manny Villafaña, its Chairman and Chief Executive
Officer, has been invited to deliver a keynote address at the Aegis Capital
Corp. 2013 Healthcare Conference on Thursday, September 26, 2013 at 8:00 p.m.,
Pacific Time, at The Encore at Wynn Las Vegas. Mr. Villafaña is also scheduled
to deliver a company presentation at the Conference earlier in the day at 8:30
a.m., Pacific Time.

About Aegis Capital Corp.

Founded in 1984, Aegis Capital Corp. is a full service retail and
institutional broker-dealer located in New York City. Aegis Capital's
management is committed to providing the highest level of service to its
clients. The firm realizes this goal by running an independent, conflict-free
platform that is focused on enhancing the goals of clients by bringing
unencumbered advice, which enables them to freely create a plan centered on
each client. Aegis Capital continues to meet the challenging and changing
markets by investing in world-class services such as access to independent
research for its financial advisors and their clients from JP Morgan,
Bloomberg, Moody's, Lipper, Best Independent Research LLC, and Argus Research.

About Kips Bay Medical

Kips Bay Medical, Inc. is a medical device company focused on manufacturing
and commercializing its external saphenous vein support technology, the eSVS
Mesh, for use in coronary artery bypass grafting surgery. The eSVS Mesh is
designed to be fitted like a sleeve on the outside of saphenous vein grafts to
strengthen SVGs used in coronary artery bypass graft surgery. By strengthening
the SVG and preventing the damaging expansion of the vein graft, the Company
hopes to reduce or prevent the resulting injury which can lead to SVG failure
and potentially costly and complicated re-interventions for patients
undergoing CABG surgery. Kips Bay originally acquired the eSVS Mesh technology
from Medtronic, Inc. in 2007.

Additional information about Kips Bay is available at the Company’s website at
www.KipsBayMedical.com.

Contact:

Kips Bay Medical, Inc.
Manny Villafaña, Chairman and Chief Executive Officer, +1-763-235-3540
Email: Manny.Villafana@KipsBayMedical.com
or
Scott Kellen, Chief Financial Officer, +1-763-235-3540
Email: Scott.Kellen@KipsBayMedical.com